• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由纳米沉淀法制备的 PLGA 纳米粒的平均粒径的微小变化会导致纳米粒的特性和细胞内递药效果发生相当大的变化。

A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery.

机构信息

a Department of Pharmaceutical Technology, Faculty of Pharmacy , Hacettepe University , Ankara , Turkey.

b Department of Pharmaceutical Technology, Faculty of Pharmacy , Erciyes University , Kayseri , Turkey.

出版信息

Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1657-1664. doi: 10.1080/21691401.2016.1276924. Epub 2017 Jan 13.

DOI:10.1080/21691401.2016.1276924
PMID:28084837
Abstract

In this study, it was aimed to investigate characteristics and intracellular delivery of two different-sized PLGA nanoparticles in ouzo region by considering number of nanoparticles. To determine the effect of formulation parameters on average particle size, Dil labeled nanoparticles were prepared using a three-factor, two-level full factorial statistical experimental design. PLGA (230.8 ± 4.32 nm) and PLGA (157.9 ± 6.16 nm) nanoparticles were obtained by altering polymer amount based on experimental design results and characterized. Same number of PLGA and PLGA nanoparticles per cell were applied onto HEK293 cells; then, cytotoxicity, uptake kinetics and mechanism were evaluated by flow cytometry and fluorescent microscopy. Also same weight of PLGA and PLGA nanoparticles were applied and cellular uptake of these nanoparticles was evaluated. It was found that PLGA nanoparticles had higher encapsulation efficiency and slower dye release compared to PLGA nanoparticles. When they were applied at same counts per cell, PLGA nanoparticles displayed faster and higher intracellular dye transfer than PLGA nanoparticles. On the other hand, PLGA appeared to be a more effective vehicle than PLGA when applied at the same weight concentration. It was also shown that for both nanoparticles, HEK293 cells employed macropinocytic, caveolae- and clathrin-mediated endocytic pathways.

摘要

在这项研究中,考虑到纳米粒子的数量,旨在通过乌佐地区两种不同大小的 PLGA 纳米粒子的特性和细胞内递送来研究。为了确定制剂参数对平均粒径的影响,使用三因素两水平完全析因统计实验设计制备 Dil 标记的纳米粒子。根据实验设计结果改变聚合物用量,获得了 PLGA(230.8±4.32nm)和 PLGA(157.9±6.16nm)纳米粒子,并对其进行了表征。将相同数量的 PLGA 和 PLGA 纳米粒子/细胞应用于 HEK293 细胞;然后通过流式细胞术和荧光显微镜评估细胞毒性、摄取动力学和机制。还应用了相同重量的 PLGA 和 PLGA 纳米粒子,并评估了这些纳米粒子的细胞摄取。结果发现,与 PLGA 纳米粒子相比,PLGA 纳米粒子具有更高的包封效率和更慢的染料释放。当以相同的细胞计数应用时,PLGA 纳米粒子比 PLGA 纳米粒子显示出更快和更高的细胞内染料转移。另一方面,当以相同的重量浓度应用时,PLGA 似乎比 PLGA 更有效。还表明,对于两种纳米粒子,HEK293 细胞均采用巨胞饮、小窝和网格蛋白介导的内吞途径。

相似文献

1
A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles' characteristics and efficacy of intracellular delivery.由纳米沉淀法制备的 PLGA 纳米粒的平均粒径的微小变化会导致纳米粒的特性和细胞内递药效果发生相当大的变化。
Artif Cells Nanomed Biotechnol. 2017 Dec;45(8):1657-1664. doi: 10.1080/21691401.2016.1276924. Epub 2017 Jan 13.
2
Fabrication and statistical optimization of surface engineered PLGA nanoparticles for naso-brain delivery of ropinirole hydrochloride: in-vitro-ex-vivo studies.表面工程化 PLGA 纳米粒的制备及其统计学优化用于盐酸罗匹尼罗的经鼻脑递药:在体-体外研究。
J Biomater Sci Polym Ed. 2013;24(15):1740-56. doi: 10.1080/09205063.2013.798880. Epub 2013 May 24.
3
Modified nanoprecipitation method to fabricate DNA-loaded PLGA nanoparticles.改良的纳米沉淀法制备载 DNA 的 PLGA 纳米粒。
Drug Dev Ind Pharm. 2009 Nov;35(11):1375-83. doi: 10.3109/03639040902939221.
4
Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.用于多西他赛口服递送的聚丙交酯-维生素E衍生物/蒙脱石纳米颗粒制剂
Biomaterials. 2009 Jul;30(19):3297-306. doi: 10.1016/j.biomaterials.2009.02.045. Epub 2009 Mar 19.
5
The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.月桂酰基封端基团对聚(D,L-乳酸-共-乙醇酸)颗粒中蛋白质释放和降解的影响。
J Control Release. 2013 Dec 10;172(2):436-43. doi: 10.1016/j.jconrel.2013.05.034. Epub 2013 Jun 7.
6
In vitro release characteristics and cellular uptake of poly(D,L-lactic-co-glycolic acid) nanoparticles for topical delivery of antisense oligodeoxynucleotides.聚(D,L-乳酸-共-乙醇酸)纳米粒经皮给药反义寡核苷酸的体外释放特性和细胞摄取。
Drug Deliv. 2011 Sep-Oct;18(7):493-501. doi: 10.3109/10717544.2011.589088. Epub 2011 Jun 22.
7
The targeting properties of folate-conjugated Pluronic F127/poly (lactic-co-glycolic) nanoparticles.叶酸偶联的 Pluronic F127/聚(乳酸-共-乙醇酸)纳米粒的靶向特性。
Int J Biol Macromol. 2017 Dec;105(Pt 1):711-719. doi: 10.1016/j.ijbiomac.2017.07.085. Epub 2017 Jul 14.
8
Preparation and characterization of vinculin-targeted polymer-lipid nanoparticle as intracellular delivery vehicle.靶向黏着斑蛋白的聚合物-脂质纳米粒的制备与表征及其作为细胞内递药载体的研究。
Int J Nanomedicine. 2013;8:39-46. doi: 10.2147/IJN.S31537. Epub 2012 Dec 28.
9
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers.聚合物乳液和交联介导的超稳定纳米粒子合成作为缓释抗结核药物载体。
Colloids Surf B Biointerfaces. 2011 Oct 15;87(2):243-54. doi: 10.1016/j.colsurfb.2011.05.025. Epub 2011 May 20.
10
Etoposide encapsulation in surface-modified poly(lactide-co-glycolide) nanoparticles strongly enhances glioma antitumor efficiency.表修饰聚乳酸-共-羟基乙酸纳米粒包封依托泊苷显著增强脑胶质瘤的抗肿瘤效率。
J Biomed Mater Res A. 2013 May;101(5):1319-27. doi: 10.1002/jbm.a.34442. Epub 2012 Oct 15.

引用本文的文献

1
Amino Acid Transporters in Glioblastoma: Implications for Diagnosis, Disease Monitoring, Therapeutic Targeting, and Drug Delivery.胶质母细胞瘤中的氨基酸转运体:对诊断、疾病监测、治疗靶点及药物递送的意义
Mol Diagn Ther. 2025 Aug 22. doi: 10.1007/s40291-025-00810-9.
2
Comparison of Drug Delivery Systems with Different Types of Nanoparticles in Terms of Cellular Uptake and Responses in Human Endothelial Cells, Pericytes, and Astrocytes.不同类型纳米颗粒的药物递送系统在人内皮细胞、周细胞和星形胶质细胞中的细胞摄取及反应比较
Pharmaceuticals (Basel). 2024 Nov 22;17(12):1567. doi: 10.3390/ph17121567.
3
2-AG-loaded and bone marrow-targeted PCL nanoparticles as nanoplatforms for hematopoietic cell line mobilization.
负载2-花生四烯酸甘油酯并靶向骨髓的聚己内酯纳米颗粒作为用于造血细胞系动员的纳米平台。
Stem Cell Res Ther. 2024 Oct 1;15(1):341. doi: 10.1186/s13287-024-03902-1.
4
Sustainable Silk-Based Particulate Systems for the Controlled Release of Pharmaceuticals and Bioactive Agents in Wound Healing and Skin Regeneration.可持续的基于丝素的微粒系统用于药物和生物活性物质在创伤愈合和皮肤再生中的控制释放。
Int J Mol Sci. 2024 Mar 8;25(6):3133. doi: 10.3390/ijms25063133.
5
Harnessing the Potential of PLGA Nanoparticles for Enhanced Bone Regeneration.利用聚乳酸-羟基乙酸共聚物纳米颗粒促进骨再生的潜力
Pharmaceutics. 2024 Feb 15;16(2):273. doi: 10.3390/pharmaceutics16020273.
6
PEG-Lipid-PLGA Hybrid Particles for Targeted Delivery of Anti-Inflammatory Drugs.用于靶向递送抗炎药物的聚乙二醇脂质聚乳酸-羟基乙酸共聚物杂化颗粒
Pharmaceutics. 2024 Jan 28;16(2):187. doi: 10.3390/pharmaceutics16020187.
7
Nanotherapeutic Heterogeneity: Sources, Effects, and Solutions.纳米治疗学的异质性:来源、影响与解决方案。
Small. 2024 Apr;20(17):e2307502. doi: 10.1002/smll.202307502. Epub 2023 Dec 5.
8
Highly Stable Docetaxel-Loaded Nanoparticles Based on Poly(D,L-lactide)--Poly(ethylene glycol) for Cancer Treatment: Preparation, Characterization, and In Vitro Cytotoxicity Studies.基于聚(D,L-丙交酯)-聚(乙二醇)的高度稳定的载多西他赛纳米颗粒用于癌症治疗:制备、表征及体外细胞毒性研究
Polymers (Basel). 2023 May 13;15(10):2296. doi: 10.3390/polym15102296.
9
Recent Development of Nanomaterials for Transdermal Drug Delivery.用于透皮给药的纳米材料的最新进展
Biomedicines. 2023 Apr 7;11(4):1124. doi: 10.3390/biomedicines11041124.
10
Characterization and Preliminary In Vitro Antioxidant Activity of a New Multidrug Formulation Based on the Co-Encapsulation of Rutin and the α-Acylamino-β-Lactone NAAA Inhibitor URB894 within PLGA Nanoparticles.基于芦丁与α-酰基氨基-β-内酯NAAA抑制剂URB894共包封于聚乳酸-羟基乙酸共聚物(PLGA)纳米粒中的新型多药制剂的表征及初步体外抗氧化活性
Antioxidants (Basel). 2023 Jan 28;12(2):305. doi: 10.3390/antiox12020305.